PERSONALIZED EARLY MEDICATION-SPECIFIC RECOMMENDATIONS FOR PATIENTS WITH ACUTE KIDNEY INJURY: FROM THE KAT-AKI TRIAL:

Category Primary study
ConferenceNational Kidney Foundation 2025 Spring Clinical Meetings
Year 2025
This article has no abstract
Epistemonikos ID: ad5d5e3cdb28f2bc9ff602473db7f3c40c7697c9
First added on: Dec 05, 2025